EBS
Emergent BioSolutions Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-27
Figures on this page computed 2026-11-08 12:28 UTC
Last close
5.90USD
Market data, 2026-11-04
Weekly closes, 2026-08-14 to 2026-11-04
Over that span: +28.5%
Except where said otherwise: 10-K for 2025, filed 2026-02-27
6.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-27
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
7.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
21.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.32 against 0.47 on the market's range.
- Growth-14.0%32 of 100, below its sector
- Returns on capital10.1%69 of 100, above its sector
- Margins56.1%75 of 100, above its sector
- Price6.2x84 of 100, above its sector
- Safety5.0147 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-02-27
- Sales0.73x
Its own average over 10 years, 1.02B.
- Profit-1.58x
Its own average over 10 years, -33.3M.
- Free cash flow3.28x
Its own average over 10 years, 47.8M.
- Debt0.81x
Its own average over 10 years, 723.6M.
- Price0.17x
Its own average over 11 years, 36. Market data, 2026-11-04
Profit is furthest from its own average, at -1.58 times.
A find tonight
The free cash flow it filed is 45.6 percent of its market value, the earnings in its last filed year are 15.3 percent of what the whole company costs, and scores 7 of Piotroski's nine tests on its last filings; it is in none of the indexes we carry (Dow Jones Industrial Average, Nasdaq-100 and S&P 500).
- Value
- 76
- Cheap
- 93
- Sound
- 58
- Unwatched
- 61
What stands out
- Safety: scores 7 of Piotroski's nine tests on its last filings, which is better than 84 percent of the companies we rank in United States.
- Price: the free cash flow it filed is 45.6 percent of its market value, which is better than 99 percent of the companies we rank in United States.
Why nobody is looking
- It is in none of the indexes we carry (Dow Jones Industrial Average, Nasdaq-100 and S&P 500).
What could make it a trap
- Altman's Z is 1.39, inside the distress band his model puts below 1.81.
- Net margin has fallen 1.32 points over five filed years.
- The share count grew 6.98 percent in the last filed year, so your slice of it is shrinking.
- Operating profit covers the interest bill only 1.69 times.
- It is down 41.5 percent over the last year, and the market may be reading something the last filing does not show.
Why it is cheap
Except where said otherwise: Computed from the filing for 2025, filed 2026-02-27
Earnings yield15.3%
Filed net income for the last annual period, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-06
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- Market data, 2026-11-06
Free cash flow yield45.6%
Filed operating cash flow less capital expenditure, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-06
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- Market data, 2026-11-06
Price to book0.7x
Market value over filed total equity
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-06
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- Market data, 2026-11-06
Cash and equivalents against market value59.8%
Filed cash and equivalents, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-06
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- Market data, 2026-11-06
Altman Z-Score1.3910-K for 2025, filed 2026-02-27
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Piotroski F-Score7.0010-K for 2025, filed 2026-02-27
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Earnings quality (Sloan accruals)1.0910-K for 2025, filed 2026-02-27
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Consecutive profitable filed years110-K for 2025, filed 2026-02-27
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Last close: Market data, 2026-11-06
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 114.7 | 159.5 | 102.0 |
| 2018-12-31 | 160.1 | 121.0 | 104.3 |
| 2019-12-31 | 226.3 | 105.2 | 106.3 |
| 2020-12-31 | 322.7 | 590.3 | 109.1 |
| 2021-12-31 | 362.9 | 423.7 | 109.7 |
| 2022-12-31 | 228.6 | -408.5 | 101.6 |
| 2023-12-31 | 214.7 | -1,468.1 | 103.9 |
| 2024-12-31 | 213.5 | -368.0 | 107.5 |
| 2025-12-31 | 152.0 | 101.5 | 115.0 |
How sales was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
Figures behind the shape
Growth
-14.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate-14.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth rate-29.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income127.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
10.1%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
Return on equity10.1%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
Return on assets4.0%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
Margins
56.1%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin56.1%
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Operating margin13.5%
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Net margin7.1%
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Free cash flow margin21.1%
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Price
6.2xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings6.2x
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-27
Price to book0.7x10-Q for 2025, filed 2026-11-03
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000112
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-11-03
- computed
- 10-K for 2025, filed 2026-02-27
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-27
Price to sales ratio0.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Safety
5.01safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-11-03
Current ratio5.0110-Q for 2025, filed 2026-11-03
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000112
- Reported in
- USD
- 10-Q for 2025, filed 2026-11-03
- 10-Q for 2025, filed 2026-11-03
Interest coverage1.7x
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Altman Z-Score1.39
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001367644-26-000015
- Reported in
- USD
- 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.